Synthesis, spectroscopy analysis, and molecular docking study of some transition metals(II) and zinc(II) complexes of mixed ligands with steroid drug and evaluate their bacterial activity

Read full text Summarise with VIRAT
Authors: Reem Natheer, Eman R. Mohammed, Amera F. Mohammed
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The new complexes of Mn+2, Co+2, Ni+2, Cu+2, and Zn2+ were formed by reacting their slats with mixed ligands of the effective anti-inflammatory drug, dexamethasone, and Eugenol or vanillin, with a ratio of 1:1:1. The prepared complexes were distinguished using physical, analytical, and spectroscopic measurements. Molar conductivity measurements in DMF solution indicated that all complexes are non-electrolytic. The information obtained from electronic spectra and magnetic moment measurements suggests that the mixed ligands coordinate to the metal ions bidentate through the two oxygen atoms of dexamethasone and the two oxygen atoms of eugenol or vanillin, and confirms the octahedral geometry for all complexes. The prepared complexes showed different activity toward Gram (+) Staphylococcus aureus, Enterococcus faecalis, and Gram (-) bacteria, Escherichia coli, and Klebsiella pneumoniae. Further molecular docking study revealed information about the prepared complexes' binding energy and interaction with the glucagon receptor GCGR. KEY WORDS: Dexamethasone, Metal complexes, Eugenol, Vanillin, Mixed ligands, Biological agents Bull. Chem. Soc. Ethiop. 2026, 40(6), 1221-1230. DOI: https://dx.doi.org/10.4314/bcse.v40i6.4

Fields of Study & Subjects

Metal complexes synthesis and properties Inorganic and Organometallic Chemistry Organometallic Compounds Synthesis and Characterization

Publication details

Journal / source
Bulletin of the Chemical Society of Ethiopia
Volume
40
Issue
6
Pages
1221–1230
Publication date
24 March 2026
Language
EN